Krsnaa Diagnostics Limited

NSE KRSNAA.NS

Krsnaa Diagnostics Limited EPS (Diluted) for the year ending March 31, 2024: USD 0.21

Krsnaa Diagnostics Limited EPS (Diluted) is USD 0.21 for the year ending March 31, 2024, a -11.58% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

Krsnaa Diagnostics Limited EPS (Diluted) for the year ending March 31, 2023 was USD 0.23, a -22.11% change year over year.
Krsnaa Diagnostics Limited EPS (Diluted) for the year ending March 31, 2022 was USD 0.30, a -62.54% change year over year.
Krsnaa Diagnostics Limited EPS (Diluted) for the year ending March 31, 2021 was USD 0.80, a 269.99% change year over year.
Krsnaa Diagnostics Limited EPS (Diluted) for the year ending March 31, 2020 was USD -0.47, a -77.85% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

NSE: KRSNAA.NS

Krsnaa Diagnostics Limited

CEO	Mr. Mitesh Dave
IPO Date	Aug. 16, 2021
Location	India
Headquarters	S.No.243,A-Hissa No.6/6
Employees	3,700
Sector	Healthcare
Industries Telehealth Biotechnology Dental Care Drugstores & Retail Pharmacies Hospitals & Clinics Medical Instruments Pharmaceuticals Utilities

Description

Krsnaa Diagnostics Limited provides diagnostic services. The company offers a range of technology-enabled diagnostic services, such as radiology, pathology/clinical laboratory, and tele-radiology services to public and private hospitals, medical colleges, and community health centers. As of December 31, 2020, it operated 1,801 diagnostic centers in 13 states across India. The company was incorporated in 2010 and is based in Pune, India.

Key trends

Past 5 years